Page last updated: 2024-11-01

nilutamide and Liver Diseases

nilutamide has been researched along with Liver Diseases in 1 studies

Liver Diseases: Pathological processes of the LIVER.

Research Excerpts

ExcerptRelevanceReference
"We report the case of a 69-year-old patient treated for stage C adenocarcinoma of the prostate with the combination of the luteinizing hormone-releasing hormone agonist [D-Trp6, des-Gly-NH2(10)] LHRH ethylamide and the antiandrogen nilutamide (Anandron) who developed simultaneous liver and lung toxicity."3.68Simultaneous liver and lung toxicity related to the nonsteroidal antiandrogen nilutamide (Anandron): a case report. ( Cusan, L; Dupont, A; Gomez, JL; Labrie, F; Tremblay, M, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gomez, JL1
Dupont, A1
Cusan, L1
Tremblay, M2
Labrie, F1

Other Studies

1 other study available for nilutamide and Liver Diseases

ArticleYear
Simultaneous liver and lung toxicity related to the nonsteroidal antiandrogen nilutamide (Anandron): a case report.
    The American journal of medicine, 1992, Volume: 92, Issue:5

    Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents; Antineoplastic Combined Chemother

1992